Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

SS - When has the company lied or misled us? In my 6-7 years...never. I look at companies every day and do DD - I get to know the PR style and the MGMT style... In my most honest opinion you will not find a better MGMT team than at IPIX. They truly care. They want the best for their shareholders.

They could have gone several different ways - RS - Uplist - etc... However they have a plan and sticking to it. The value that these drugs could possibly bring to market are extreme - imo they have 3 blockbusters on hand and have not failed a trial.


Lets REVISIT:

___________________________________________________
BEVERLY, MA – January 29, 2018 (GLOBE NEWSWIRE) Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides a business development update:

· The Confidential Disclosure Agreement (CDA) count toward partnering with global and specialty pharmaceutical companies interested in the Company’s first-in-class drug candidates is nearing 20, with additional Agreements in review. Successfully securing partnerships would afford the Company access to immediate and potentially recurring sources of non-dilutive capital, including upfront fees, milestone-based payments and tiered royalties;

· A leading international drug manufacturer has been engaged with to bulk produce commercial-quality Brilacidin, aimed at lowering patient drug cost and anticipating future drug needs in preparation for expedient market introduction. This critical step also proactively facilitates future patient and insurance reimbursement adoption through favorable cost savings;

· After a recent successful Phase 2 trial in Oral Mucositis (OM), the Company believes that it is the clear global leader in this area as it develops an easy-to-administer oral rinse medicine for the prevention of severe Oral Mucositis (SOM) in Head and Neck Cancer (HNC) patients receiving chemoradiation—analysts estimate this market could reach $1 billion in coming years.

Brilacidin—Dermatology Formulation Development

Brilacidin has successfully completed Phase 2 trials in Oral Mucositis (OM), Inflammatory Bowel Disease (IBD) and Acute Bacterial Skin and Structure Infection (ABSSSI). A drug with broad platform potential (pdf), Brilacidin’s innate properties and modes of action, as well as additional pre-clinical work, support the drug’s potential for topical application in dermatology, including: Atopic Dermatitis, Acne, and Hidradenitis Suppurativa. All are areas of large unmet need and comprise highly lucrative markets.

To further these efforts, the Company is in negotiations with a leading drug formulator to develop topical formulation(s) of Brilacidin for these three dermatology indications, starting in 1H2018. The goal of the negotiations is to reach terms on a strategic partnership for addressing these markets. The formulator brings an impressive track record of developing products that have earned billions of dollars for global pharmaceutical companies.

For a discussion on Brilacidin’s potential as a topical agent in dermatology, please read more at the following link:

· “Brilacidin’s Potential Application in Dermatology”

For more on Brilacidin, learn more here:

· http://www.ipharminc.com/brilacidin-1/
__________________________________________________________


That is in fact alot going on for a SMALL BIOTECH. Not to mention unblinding Prurisol data alone and attempting to make the first ever safe P53 drug into ORAL!

This board is toxic and again has spun-up FEAR and LIES.
We can't stop it and Leo knows that. But for all the true investors, just know that this board is the furthest from the truth and what is really going on with the company. They are hard at work every day --- entertaining many questions and possible offers and giving more and more detail to their pipeline to BP and BIO's all while running a business and moving forward. It is not a small task to do so.

As KarinCA suggested - watching IPIX over the years, to let go workers is on par. Dr. J - gone - when done with getting B thru phase 2b. One example. All Trials are currently done! ALL TRIALS ARE CURRENTLY DONE! So there is no need for many right now. If I was a betting man...I'd say we are about to partner and use another companies resources for the rest of the way. JMO